Slow-responders to IV β2-adrenergic agonist therapy: Defining a novel phenotype in pediatric asthma

Pediatric Pulmonology

Volumn 43, Issue 7, 2008, Pages 627-633

  Carroll, Christopher L ^a   Schramm, Craig M ^a   Zucker, Aaron R ^a  

^a Farmington   (United States)

Author keywords

Asthma; Pediatrics; Phenotype

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; MAGNESIUM; METHYLPREDNISOLONE; PREDNISONE; SALBUTAMOL; TERBUTALINE;

ADOLESCENT; ARTICLE; ARTIFICIAL VENTILATION; ASPIRATION PNEUMONIA; ASTHMA; ASTHMATIC STATE; CHILD; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; CHRONIC DISEASE; CLINICAL PROTOCOL; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG INFUSION; ENDOTRACHEAL INTUBATION; ENDOTRACHEAL TUBE; FEMALE; GENETIC POLYMORPHISM; HEART RATE; HUMAN; INFECTIOUS COMPLICATION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL NEBULIZER; PATIENT MONITORING; PHENOTYPE; PNEUMOMEDIASTINUM; PNEUMOTHORAX; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RHABDOMYOLYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TACHYCARDIA; TREATMENT OUTCOME; ULCER PERFORATION;

ADOLESCENT; ADRENERGIC BETA-AGONISTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; PHENOTYPE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STATUS ASTHMATICUS; TERBUTALINE; TREATMENT OUTCOME;

EID: 46849097174     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20846     Document Type: Article

References (30)

1. Werner HA. Status asthmaticus in children. Chest 2001;119:1913-1929.
2. Siwik JP, Nowak RM, Zoratti EM. The evaluation and management of acute, severe asthma. Med Clin North Am 2002;86:1049-1071.
3. Baren JM, Zorc JJ. Contemporary approach to the emergency department management of pediatric asthma. Emerg Med Clin North Am 2002;20:115-138.
4. Smith SR, Strunk RC. Acute asthma in the pediatric emergency department. Emerg Med 1999;46:1145-1165.
5. Wheeler DS, Jacobs BR, Kenreigh CA, Bean JA, Hutson TK, Brilli RJ. Theophylline versus terbutaline in treating critically ill children with status asthmaticus: a prospective, randomized, controlled trial. Pediatr Crit Care 2005;6:142-147.
6. Bogie AL, Towne D, Luckett PM, et al. Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus. Pediatr Emerg Care 2007;23:355-361.
7. Stephanopoulos DE, Monge R, Schell KH, Wyckoff P, Peterson B. Continuous intravenous terbutaline for pediatric status asthmaticus. Crit Care Med 1998;26:1744-1748.
8. Travers AH, Rowe BH, Barker S, Jones A, Camargo CA. The effectiveness of IV beta-agonists in treating patients with acute asthma in the emergency department: a meta analysis. Chest 2002;122:1200-1207.
9. Carroll CL, Schramm CM. Administering IV terbutaline based on severity of illness shortens ICU length of stay in pediatric status asthmaticus. Pediatr Pulmonol 2006;41:350-356.
10. Carroll CL, Sekaran AK, Lerer TJ, Schramm CM. A modified pulmonary index score with predictive value for pediatric asthma exacerbations. Ann Allergy Asthma Immunol 2005;94:355-359.
11. National Asthma Education and Prevention Program (NAEPP) Expert Panel: Guidelines for the Diagnosis and Management of Asthma-Update on Selected Topics 2002. Bethesda, Maryland: National Heart, Lung and Blood Institute; 2002; NIH Publication No. 02-5075.
12. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States advance data from vital and health statistics, no. 314. Hyattsville, MD: National Center for Health Statistics, 2000.
13. Bush A. Classification of phenotypes. Pediatr Pulmonol 2004;26:30-33.
14. Martinez FD. Development of wheezing disorders and asthma in preschool children. Pediatrics 2002;109:362-367.
15. Bel EH. Clinical phenotypes of asthma. Curr Opin Pulm Med 2004;10:44-50.
16. Bottema RWB, Neijmerink NE, Koppelman GH, Kerkhof M, Postma DS. Phenotype definition, age, and gender in the genetics of asthma and atopy. Immunol Allergy Clin N Am 2005;25:621-639.
17. Wenzel SE, Covar R. Update in Asthma 2005. Am J Respir Crit Care Med 2006;173:698-706.
18. Reihsaus E, Innis M, MacIntyre N, Liggett SB. Mutations in the gene encoding for the beta-2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993;8:334-339.
19. Contopoulos-Ioannidis DG, Manoli EN, Ioannidis JP. Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes. J Allergy Clin Immunol 2005;115:963-972.
20. Joos L, Pare PD, Sandford AJ. β2-adrenergic receptor polymorphisms and asthma. Curr Opin Pulm Med 2001;7:69-74.
21. Lima JJ, Thomason DB, Mohamed MH, Eberle LV, Self TH, Johnson JA. Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics. Clin Pharmacol Ther 1999;65:519-525.
22. Tan S, Hall IP, Dewar J, Dow E, Lipworth B. Association between beta 2-adrenoceptor polymorphism and susceptibility to bronchodilator densitisation in moderately severe stable asthmatics. Lancet 1997;350:995-999.
23. Liggett SB. Polymorphisms of the β2-adrenergic receptor and asthma. Am J Respir Crit Care Med 1997;156:S156-162.
24. Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, Duffy D, Thompson J, Hall I, Kaufman J, Leung T, Helms PJ, Hakonarson H, Halpi E, Navon R, Attia J. Systematic review and meta-analysis of the association between β2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 2005;162:201-211.
25. Burchard EG, Avila PC, Nazario S, Casal J, Torres A, Rodriguez-Santana JR, et al. Genetics of Asthma in Latino Americans (GALA) Study. Lower bronchodilator responsiveness in Puerto Rican than in Mexican subjects with asthma. Am J Respir Crit Care Med 2004;169:386-392.
26. Choudhry S, Ung N, Avila PC, Ziv E, Nazario S, Casal J, et al. Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma. Am J Respir Crit Care Med 2005;171:563-570.
27. Carroll CL, Zucker AR. The increased cost of complications in children with status asthmaticus. Pediatr Pulmonol 2007;42:914-919.
28. Carroll CL, Bhandari A, Schramm CM, Zucker AR. Chronic inhaled corticosteroids do not affect acute severe asthma exacerbations in children. Pediatr Pulmonol 2006;41:1213-1217.
29. Casati A, Putzu M. Anesthesia in the obese patient: pharmacokinetic considerations. J Clin Anesth 2005;17:134-145.
30. National Asthma Education and Prevention Program (NAEPP) Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, Maryland: National Heart, Lung and Blood Institute; 2007; NIH Publication No. 07-4051.